Improvement of hyperglycemia through dietotherapy/herbal remedy is an effective approach to treating diabetes. In this study, mulberry leaf, famous for silkworm’s special food and therapeutic value without any side effects, alleviated diabetes by attenuating NEFA signaling and modulating intestinal microflora. Mulberry leaf treatment significantly reduce fasting blood-glucose and HbA1c, ameliorate the blood lipid profile and improve insulin resistance in streptozotocin-induced diabetic rats. Mechanistically, we found that mulberry leaf inhibited NEFA signaling by reducing downstream signaling in the NEFA pathway, further verified by reduced PKC and improved cellular energy homeostasis based on restored expression of PGC-1α, AK2, OXPHOS and adiponectin. Mulberry leaf treatment also restored the phyla Bacteroidetes and Proteobacteria and class Clostridia, which were associated with insulin resistance and diabetes. Our findings reveal that mulberry leaf is an edible with therapeutic potential for diabetes and may provide a novel dietotherapy/herbal remedy to the treatment of diabetes.
BACKGROUND: Chlorogenic acid is a type of phenolic acid found in many plants. Chlorogenic acid has an anti-obesity effect with an unclear mechanism. The present study aimed to investigate the regulatory effect of chlorogenic acid on energy balance in high-fat diet (HFD) induced obese C57BL/6J mice administrated 100 mg kg-1 chlorogenic acid for 13 weeks. RESULTS: The consumption of chlorogenic acid ameliorated HFD induced obesity. Chlorogenic acid did not change the physical activity but significantly decreased food intake and increased body temperature, thermal dissipation and brown adipose tissue activity. Moreover, chlorogenic acid improved glucose tolerance but had a moderate impact on other blood indices. Additionally, chlorogenic acid failed to restore the microbiota change associated with HFD induced obesity, but modified the gut bacterial composition in a unique way. CONCLUSION: Supplementation with chlorogenic acid can improve HFD induced obesity and associated glucose intolerance mainly via regulating food intake and energy expenditure.
Previous studies have reported the therapeutic effects of oleuropein (OP) consumption on the early stage of type 2 diabetes. However, the efficacy of OP on the advanced stage of type 2 diabetes has not been investigated, and the relationship between OP and intestinal flora has not been studied. Therefore, in this study, to explore the relieving effects of OP intake on the advanced stage of type 2 diabetes and the regulatory effects of OP on intestinal microbes, diabetic db/db mice (17-week-old) were treated with OP at the dose of 200 mg/kg for 15 weeks. We found that OP has a significant effect in decreasing fasting blood glucose levels, improving glucose tolerance, lowering the homeostasis model assessment–insulin resistance index, restoring histopathological features of tissues, and promoting hepatic protein kinase B activation in db/db mice. Notably, OP modulates gut microbiota at phylum level, increases the relative abundance of Verrucomicrobia and Deferribacteres, and decreases the relative abundance of Bacteroidetes. OP treatment increases the relative abundance of Akkermansia, as well as decreases the relative abundance of Prevotella, Odoribacter, Ruminococcus, and Parabacteroides at genus level. In conclusion, OP may ameliorate the advanced stage of type 2 diabetes through modulating the composition and function of gut microbiota. Our findings provide a promising therapeutic approach for the treatment of advanced stage type 2 diabetes.
The
global pandemic of diabetes and diabetes complications confers
heavy pressure on public health. Novel antidiabetes strategies with
negligible unwanted effects are urgently needed. Currently, the anti-hyperglycemic
potential of plant-based functional ingredients has been explored
to provide alternative strategies. As a kind of dietary bioactive
compound, oleuropein has aroused the growing interest of researchers
in diabetes and diabetes complications management. This review reveals
the research progress of oleuropein in treating diabetes and diabetes
complications and summarizes the molecular mechanisms involved in
these beneficial effects of oleuropein. Oleuropein achieves amelioration
of diabetes, the mechanisms of which include the modulation of insulin
secretion, the repairment islet morphology, the activation of hepatic
AMP-activated protein kinase singling, and the improvement of glucose
tolerance and insulin resistance. Oleuropein also can relieve diabetes
complications including diabetic nephropathy, diabetes cardiovascular
complications, diabetic retinopathy, poor wound healing, diabetic
neuropathy, and diabetic testicular dysfunction. Oleuropein reverses
cell apoptosis, regenerates tissues, restores the histological organization,
and decreases oxidative stress in treating diabetes complications.
Taken together, oleuropein is a promising compound for diabetes and
diabetes complications management and can be used as a nutraceutical
to fight against these diseases.
HIGHLIGHTS Allicin reduces adiposity and maintains glucose homeostasisAllicin activates the brown adipocytes and increases the energy expenditure Allicin enhances BAT activity partly through SIRT1-PGC1a-Tfam signaling pathway Allicin regulates mitophagy via suppressed sirt5-mediated succinylation accumulation
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.